Softball Athlete Suspended for the Presence of Pseudoephedrine

Ottawa – February 12, 2024 – The Canadian Centre for Ethics in Sport (CCES) announced today that Mitchell McKay, a softball athlete, received an 18-month sanction for an anti-doping rule violation. The athlete’s urine sample, collected in-competition on August 2, 2023, revealed the presence of pseudoephedrine, a prohibited specified stimulant.

In response to the CCES’s notification of the adverse analytical finding, the athlete signed an Agreement on Consequences thereby waiving their right to a hearing and accepting the proposed sanction and all other applicable consequences. Because the athlete accepted a voluntary provisional suspension on September 7, 2023, the sanction ends on March 6, 2025.

During the sanction period, the athlete is ineligible to participate in any capacity with any sport signatory to the Canadian Anti-Doping Program (CADP), including training with teammates.

In compliance with rule 8.4 of the CADP, the CCES’s file outcome summary can be found in the Canadian Sport Sanction Registry.

About the CCES

The CCES works collaboratively to ensure Canadians have a positive sport experience. Through its programs, the CCES manages unethical issues in sport, protects the integrity of Canadian sport, and promotes True Sport to activate values-based sport on and off the field of play. The CCES is an independent, national, not-for profit organization that is responsible for the administration of the CADP. Under the CADP rules, the CCES makes public every anti-doping rule violation. For more information, visit, follow us on X (Twitter), Facebook, or Instagram.

-- 30 --

For further information, please contact:

+1 613-521-3340 x3233
[email protected]

See Also...

Canadian Anti-Doping Program

The 2021 Canadian Anti-Doping Program came into effect on January 1, 2021, ensuring the program’s ongoing compliance with the World Anti-Doping Code.